Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)

By sjmartinez • April 25, 2023

Fakih M, Harb W, Mahadevan D, Babiker H, Berlin J, Lillie T, Krige D, Carter J, Cox C, Patel M, Parfitt L, Powell M, Rosen L. Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE). J Immunother Cancer. 2023 Apr;11(4):e006561. doi: 10.1136/jitc-2022-006561. PMID: 37094988.

Tags: clinical trials as topic, Hematology/Oncology, immunotherapy, Investigational, oncolytic viruses, Publications, Therapies

B7-H3-liquid biopsy for the characterization and monitoring of the dynamic biology of prostate cancer

Ju Y, Watson J, Wang JJ, Yen YT, Gevorkian L, Chen Z, Tu KH, Salumbides B, Phung A, Zhao C, Kim H, Ji YR, Zhang[...]

Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentary

Bardia A. Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentary. Clin Adv Hematol Oncol. 2025 Feb;23 Suppl 2(1):6-15. PMID:[...]

Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan[...]